Skip to main content

GTS SECURITIES LLC

Broker-Dealer

Position in NVS — Novartis AG

CIK 1452765 NEW YORK, NY

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$610,737
+$332,516 QoQ
Shares Held
3,897
+93.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#802
of 1,603 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Derivatives in NVS

reported options exposure · as of Sep 30, 2024
CallValue
$9,374,130
CallShares
81,500
PutValue
$5,635,980
PutShares
49,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

GTS SECURITIES LLC holds $12,976,736 across 10 Drug Manufacturers - General names. NVS ranks #8 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 NVS
Novartis AG
This page
3,897 $610,737

All Filings in NVS

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $610,737 3,897
2025-12-31 $278,221 2,018
2025-09-30 $1,604,538 12,512
2025-06-30 $619,813 5,122
2025-03-31 $469,219 4,209
2024-12-31 $939,041 9,650
2024-09-30 $9,374,130 81,500
2024-09-30 $5,635,980 49,000
2024-09-30 $942,013 8,190
2024-06-30 $3,396,074 31,900
2024-06-30 $3,577,056 33,600
2024-03-31 $3,472,607 35,900
2024-03-31 $2,331,193 24,100
2023-12-31 $8,148,279 80,700
2023-12-31 $7,451,586 73,800
2023-09-30 $10,389,720 102,000
2023-09-30 $9,625,770 94,500